UPDATED Apr 26, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LAB | €1.65 | 6.5% | -45.0% | €11.7m | €2.40 | PB2.5x | E94.2% | n/a | Pharmaceuticals & Biotech | ||
SQRL | €1.54 | 2.3% | -36.0% | €136.6m | n/a | PE9.7x | E16.1% | n/a | Media | ||
ATRY | €2.88 | -2.4% | -43.3% | €218.7m | €6.61 | PS1.1x | E146.4% | n/a | Healthcare | ||
ROVI | €85.00 | 7.1% | 111.5% | €4.4b | €81.48 | PE25.9x | E16.6% | 1.3% | Pharmaceuticals & Biotech | ||
SAN | €4.85 | 7.5% | 52.2% | €75.8b | €5.19 | PB0.8x | E2.4% | 3.9% | Banks | ||
SAB | €1.69 | 13.9% | 79.0% | €9.2b | €1.83 | PB0.6x | E-5.5% | 3.5% | Banks | ||
AGIL | €4.30 | 4.9% | 8.6% | €98.9m | €6.50 | PE4441.1x | E-74.1% | n/a | Software | ||
ELZ | €0.17 | -2.9% | -40.2% | €20.7m | n/a | PB0.4x | n/a | n/a | Materials | ||
TRG | €0.64 | -2.0% | -21.1% | €110.6m | n/a | PE2x | n/a | 0% | Materials | ||
YP3L | €10.50 | 0% | 35.5% | €132.5m | n/a | PS3.6x | n/a | n/a | Real Estate Management and Development |